文献速递心外重症与机械循环支持

左心室辅助装置植入时同期三尖瓣修复可能增加临时右心室支持风险但不影响总体结局

Concomitant tricuspid valve repair in left ventricular assist device implantation may increase the risk for temporary right ventricular support but does not impact overall outcomes.
PubMed 文献 · Eur J Cardiothorac Surg · 2022-01-01

这项回顾性多中心研究纳入2005至2017年接受连续流左心室辅助装置植入的成年患者,比较同期行三尖瓣修复者与未行者。526例中110例(21%)同期行三尖瓣修复,该组临时右心室辅助装置发生率显著更高(18% vs 11%,P=0.049),校正混杂后大多数临床结局包括右心衰相关再住院(P=0.891)与死亡(P=0.563)无显著差异。

要点

  • 526例中110例(21%)同期行三尖瓣修复,该组患者病情更重,多为中度或重度三尖瓣反流。
  • 同期三尖瓣修复组临时右心室辅助装置发生率18% vs 11%(P=0.049),风险sHR 1.68(95%CI 1.04-2.72;P=0.037)。
  • 校正混杂因素后,右心衰相关再住院(P=0.891)与死亡(P=0.563)等大多数结局无显著差异。

核心结论

  • 左心室辅助装置植入时如认为必要行同期三尖瓣修复,可能增加需临时右心室辅助装置的早期右心衰风险,但不影响死亡或晚期右心衰所致再住院的发生率或风险。

研究设计与样本

  • 回顾性、多中心研究,纳入2005至2017年接受连续流左心室辅助装置植入的成年患者,比较同期行三尖瓣修复者与未行者。
  • 共526例接受左心室辅助装置植入,其中110例(21%)同期行三尖瓣修复。

主要发现

  • 同期三尖瓣修复组患者病情更重,多数为中度或重度三尖瓣反流。
  • 同期三尖瓣修复组临时右心室辅助装置发生率显著更高(18% vs 11%,P=0.049)。
  • 同期三尖瓣修复组临时右心辅助装置风险显著升高(sHR 1.68,95%CI 1.04-2.72;P=0.037)。
  • 校正混杂因素后,大多数临床结局的发生率与风险无显著差异,包括右心衰相关再住院(P=0.891)与死亡(P=0.563)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Tricuspid valve repair in left ventricular assist device implantation continues to pose a challenge and may impact the occurrence of early and late right heart failure. We investigated the effects of concomitant tricuspid repair on clinical outcomes. METHODS: A retrospective, multicentre study enrolled adult patients who received continuous-flow left ventricular assist devices between 2005 and 2017 and compared those who received concomitant tricuspid valve repair to those who did not. Primary outcomes were early right heart failure necessitating temporary ventricular assist devices and right heart failure-related rehospitalizations requiring inotropic or diuretic treatment. RESULTS: Out of 526 patients who underwent left ventricular assist device implantation, 110 (21%) received a concomitant tricuspid valve repair. Those patients were sicker, and most had moderate or severe tricuspid regurgitation. A significantly higher incidence of temporary right ventricular assist devices was observed in the group with concomitant tricupid valve repair (18% vs. 11%, P = 0.049), with a significantly elevated risk for temporary right heart assist device (sHR 1.68, 95% CI 1.04-2.72; P = 0.037). After adjusting for confounders, no significant differences were found in the incidence of and risk for most clinical outcomes, including right heart failure-related rehospitalizations (P = 0.891) and death (P = 0.563). CONCLUSIONS: Concomitant tricuspid valve repair, when deemed necessary in left ventricular assist device implantation, may increase the risk of early right heart failure requiring a temporary right ventricular assist device but does not impact the incidence or risk of death or rehospitalizations due to late right heart failure.

来源:Eur J Cardiothorac Surg,查看原文。版权归原作者所有。

引用

  1. Mihalj M, Jezovnik MK, Benk J, et al. Concomitant tricuspid valve repair in left ventricular assist device implantation may increase the risk for temporary right ventricular support but does not impact overall outcomes. Eur J Cardiothorac Surg. 2022. PMID: 36469336. doi:10.1093/ejcts/ezac555

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。